Hypothetical Case: An Internal Research Evaluation

Frame the decision before requesting access

A fictional research team wants to know whether a model's daily observations would improve the organization of its internal review work. The proposed evaluation does not involve client reporting, order generation or a live account. Its decision is whether to pursue further procurement, not whether to deploy the model or promise an investment outcome.

The team names a research reviewer, an integration reviewer and a procurement owner. It records three questions: can the outputs be interpreted, can a documented sample be reproduced, and can delivery exceptions be investigated? Historical investment evidence is a separate review item. The team does not expect a short integration exercise to establish returns or resilience across market conditions.

Set permissions and resource boundaries

Before using real supplied material, procurement requests an evaluation scope identifying the entity, reviewers, input sources and proposed retention. No permission is assumed to have been granted in this case. WIPO's technology-transfer guidance distinguishes licence arrangements from confidentiality arrangements, prompting the buyer to ask about both rather than treating a nondisclosure signature as unrestricted evaluation access.

Qualified reviewers would examine the actual agreement and relevant jurisdiction before the proposed use begins. While questions remain open, the team can design its checks using invented records. It caps analyst and engineering effort, excludes production credentials and schedules a decision meeting. Any later deployment or client communication would require a separately reviewed scope and approval process.

Freeze a synthetic acceptance worksheet

For illustration, the buyer designs a fixture with twenty scheduled sessions and twenty-five instrument records per session. That creates 20 x 25 = 500 expected records. It sets a buyer-chosen 98% usable-record threshold and also requires an explanation for every exception. These are fictional acceptance choices, not contractual commitments or recommended thresholds for every model.

The model identifier, schema and timestamp definitions would be frozen before a real evaluation. The 2026 interagency model-risk guidance provides context for testing suited to intended use; its banking scope does not certify this fictional exercise. The buyer separately records that parsing checks, sample reconciliation and historical strategy validation answer different questions and cannot substitute for one another.

Reconcile the invented observations

The synthetic worksheet contains 480 usable records and twenty unresolved records, split into twelve missing identifiers and eight ambiguous availability timestamps with no overlap. Usable coverage is 480 / 500 = 96%. Meeting the numerical 98% threshold would require at least 490 usable records, but the separate requirement to explain exceptions would still apply.

The reviewer does not remove the twenty unresolved records from the denominator. Doing so would misleadingly turn 480 divided by 480 into apparent completeness. Instead, the worksheet preserves both exception categories and identifies the information needed to resolve them. These invented observations test the buyer's review procedure; they describe no real supplier's service or investment performance.

Choose a bounded next step

The fictional committee places the proposed integration decision on hold. It requests identifier definitions and timestamp evidence, with a limited retest only if those clarifications address the gaps. It makes no claim that the model is economically unsuccessful. A delivery-evidence problem does not establish a negative strategy result, just as a repaired import would not establish a positive one.

Any retest would retain the original worksheet and explain the repair. Previously inspected records would not become an untouched investment sample. If the clarification cannot be obtained within the agreed evaluation resources, the buyer can decline or defer procurement for insufficient evidence. The decision would state that reason directly rather than inventing a performance conclusion.

Close access and preserve the decision

At closure, the buyer would disable temporary access and retain only material permitted or required under the reviewed arrangements and applicable obligations. The decision record identifies the proposed use, tested questions, unresolved exceptions and limits of the evidence. It avoids calling the exercise certification, and it does not imply that a subscription or deployment has been approved.

The lesson is a procurement workflow, not a success story about a client. The buyer reaches a useful bounded conclusion: more evidence is needed for the stated integration purpose. That conclusion remains separate from legal permission, research merit and execution readiness, leaving each responsible reviewer with a precise question rather than a misleading aggregate pass label.

• Keep unresolved records in the denominator.
• State the reason for a hold without inventing a performance verdict.

Source notes

1. WIPO: Technology Transfer Agreements
2. Federal Reserve, FDIC and OCC: Supervisory Guidance on Model Risk Management, April 2026